Important safety warnings seek urgent medical attention if you experience: Severe or persistent abdominal pain, which may radiate to the back this could indicate pancreatitis , a serious but rare risk associated with GLP-1based therapies as a class [16] [17] Right upper quadrant pain, fever, or jaundice these may suggest gallbladder disease , another class-associated risk Signs of dehydration (dizziness, reduced urine output, extreme thirst) resulting from severe vomiting or diarrhoea, which can affect kidney function Pregnancy and breastfeeding: Use of GLP-1based therapies and related investigational agents is not recommended during pregnancy or breastfeeding
Zepbound (injectable pen): Zepbound contains the same tirzepatide molecule as Mounjaro and follows identical storage guidelines
In certain cases, an ultrasound-guided liver biopsy may also be conducted
These multifaceted actions have led to the development of GLP-1 receptor agonists (GLP-1 RAs) as effective therapeutic agents in both conditions
Generally, a teaspoon of amla powder or a small glass of amla juice is a good starting point
That set up up a future regulatory disaster